Central Serous Chorioretinopathy
Information
- Disease name
- Central Serous Chorioretinopathy
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05278169 | Active, not recruiting | Central Serous Chorioretinopathy Registry and Pachychoroid Observation and Natural History Study | March 11, 2022 | December 31, 2024 | |
| NCT03339856 | Completed | N/A | Selective Retina Therapy With Real-Time Feedback-Controlled Dosimetry for Treating Acute Idiopathic Central Serous Chorioretinopathy in Korean Patients | January 1, 2017 | October 1, 2017 |
| NCT05847049 | Completed | Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta Chment in Central Serous Chorioretinopathy | February 28, 2023 | April 6, 2023 | |
| NCT00802906 | Completed | N/A | Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC) | May 2007 | December 2010 |
| NCT00803517 | Completed | Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy | March 2008 | October 2008 | |
| NCT00817245 | Completed | Phase 1/Phase 2 | Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR) | March 2008 | January 2009 |
| NCT00963131 | Completed | Phase 2 | High-dose Antioxidants for Central Serous Chorioretinopathy | December 2004 | June 2009 |
| NCT00987077 | Completed | Phase 2 | Selective Retina Therapy (SRT) in Patients With Idiopathic Central Serous Retinopathy | April 2007 | January 2009 |
| NCT01019668 | Completed | N/A | Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy | November 2008 | June 2011 |
| NCT01327170 | Completed | N/A | Micropulse Diode Laser Treatment for Chronic Central Serous Chorioretinopathy | November 2008 | June 2010 |
| NCT01378130 | Completed | Central Serous Chorioretinopathy: Etiology, Course and Prognosis | April 2011 | April 2013 | |
| NCT01574430 | Completed | Phase 4 | Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC) | December 2010 | December 2014 |
| NCT05686421 | Completed | N/A | Comfortable and Stabilizing Chin & Forehead Rest Attachment for Slit Lamp Configurations | March 30, 2023 | April 28, 2023 |
| NCT03758963 | Completed | N/A | Selective Retina Therapy With 'R:GEN' in Patients With Central Serous Chorioretinopathy | March 30, 2016 | June 20, 2018 |
| NCT03497000 | Completed | N/A | Effects of OCTA-guided PDT in Acute CSC | September 1, 2017 | March 27, 2018 |
| NCT01710332 | Completed | Phase 2 | The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy | October 2012 | June 2013 |
| NCT01822561 | Completed | Phase 2 | Eplerenone for Central Serous Chorioretinopathy | May 2013 | December 2017 |
| NCT01880788 | Completed | Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD | November 2012 | August 2015 | |
| NCT01971190 | Completed | Phase 2 | Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy | October 2013 | May 2015 |
| NCT05104138 | Completed | Eplerenone Versus PDT: Comparative Study by OCTA | October 1, 2015 | November 30, 2017 | |
| NCT01990677 | Completed | N/A | Eplerenone for the Treatment of Central Serous Chorioretinopathy | October 2013 | May 2015 |
| NCT04723160 | Completed | Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph | August 10, 2020 | May 30, 2021 | |
| NCT00403325 | Completed | Phase 1 | Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy | August 2006 | |
| NCT04224831 | Completed | N/A | Treatment of Chronic Central Serous Chorioretinopathy Via Electromagnetic Stimulation and Platelet- Rich Plasma | December 1, 2018 | January 1, 2020 |
| NCT03950089 | Completed | Optical Coherence Tomography Angiography (OCT-A) and Central Serous Chorioretinopathy (CSC) | July 1, 2016 | September 30, 2017 | |
| NCT02354170 | Completed | Phase 2 | Short-Term Oral Mifepristone for Central Serous Chorioretinopathy | January 2015 | April 27, 2017 |
| NCT05687422 | Not yet recruiting | N/A | Two Patterns of Micropulse Laser in the Treatment of Chronic Central Serous Chorioretinopathy | February 1, 2023 | December 31, 2023 |
| NCT06346405 | Recruiting | Central Serous Chorioretinopathy and Micropulse Laser Treatment | May 31, 2023 | May 31, 2025 | |
| NCT02141308 | Recruiting | OCT in Rare Chorioretinal Diseases | May 2014 | December 2026 | |
| NCT05570591 | Recruiting | N/A | Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy | October 18, 2022 | December 31, 2023 |
| NCT05589974 | Recruiting | Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy | October 1, 2022 | July 31, 2026 | |
| NCT02088151 | Terminated | N/A | Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina | June 2010 | February 1, 2022 |
| NCT02889185 | Terminated | N/A | Multimodal Imaging in Central Serous Chorioretinopathy | April 2016 | December 4, 2018 |
| NCT01982383 | Terminated | N/A | Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy | November 2012 | November 2015 |
| NCT02215330 | Unknown status | Phase 2/Phase 3 | A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy | October 2014 | September 2017 |
| NCT02153125 | Unknown status | Phase 2 | Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy | April 2014 | |
| NCT04410861 | Unknown status | N/A | Panmacular Versus Minimal Micropulse Laser Therapy in Central Serous Chorioretinopathy | June 1, 2020 | January 1, 2022 |
| NCT04665102 | Unknown status | Pilot Study on Deep Learning in the Eye | February 1, 2021 | December 1, 2022 | |
| NCT01633983 | Unknown status | Phase 2 | Methotrexate for Central Serous Chorioretinopathy Treatment Trial | August 2012 | July 2015 |
| NCT05337332 | Unknown status | Phase 2/Phase 3 | Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases | April 14, 2022 | June 1, 2023 |
| NCT05390619 | Unknown status | N/A | Different Doses of vPDT in the Treatment of cCSC | January 1, 2020 | December 31, 2023 |
| NCT00403884 | Unknown status | N/A | Selective RPE Laser Treatment (SRT) for Various Macular Diseases | October 2004 | August 2010 |
| NCT02815176 | Unknown status | Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markers | June 2016 | June 2017 | |
| NCT03692169 | Unknown status | The Changes of Retinal Capillaries After Half-dose PDT Measured by OCTA in Eyes With CSC | October 31, 2016 | June 30, 2019 | |
| NCT02681783 | Unknown status | Phase 4 | PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept | December 1, 2018 | December 1, 2022 |
| NCT00864773 | Unknown status | N/A | The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy | March 2009 | March 2010 |
| NCT03542006 | Unknown status | Phase 2 | Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy | June 1, 2018 | April 1, 2019 |
| NCT01630863 | Unknown status | N/A | The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy | June 2012 | March 2015 |
| NCT05679180 | Withdrawn | N/A | Navigated Microsecond Laser for Chronic Central Serous Chorioretinopathy: MICROPULSE | May 11, 2023 | May 24, 2023 |
| NCT00418431 | Withdrawn | Phase 2/Phase 3 | Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy | April 2006 | August 2006 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0025567
- MedGen concept unique identifier (MedGen Concept name)
- C0730328
- MedGen unique identifier (MedGen Concept name)
- 147591
- MeSH unique ID (MeSH (Medical Subject Headings))
- D056833